Facebook Linkedin Twitter
Inside Precision Medicine Shortening of CAR-T Cell Monitoring Period Could Improve Accessibility

Lymphoma

3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Shortening of CAR-T Cell Monitoring Period Could Improve Accessibility

Helen Albert -
0
HIV viruses, illustration
News & Features

Second HIV Patient “Cured” with Stem Cell Transplant at Charité, Using Slightly Different Genetic Recipe

Malorye Branca -
0
Hodgkin lymphoma, light micrograph
News & Features

CAR-T Targeting CD22 Delivers Positive Early Results in Lymphoma 

Malorye Branca -
0
Immunoglobulin G—IgG—antibody molecule
News & Features

Frequent Immunoglobulin Testing Reduces Infections in CLL and NHL Patients

Chris Anderson -
0
Diffuse large B-cell lymphoma
News & Features

Combination Targeted Therapy Regimen Potentially Practice-Changing for DLBCL

Laura Cowen -
0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Studies Address Risk for Secondary Cancers Related to CAR T Cell Therapy

Laura Cowen -
0
Under attack dissolving human heart
Molecular Dx

SHORE’d-up: Heart Transplant Rejection Diagnostic Outperforms Biopsies

Jonathan D. Grinstein, PhD -
0
CAR T cell immunotherapy, illustration
News & Features

Altering CAR Proteins Improves T Cells’ Ability to Attack Solid Tumors

Chris Anderson -
0
CAR T cell immunotherapy
News & Features

New Technique Improves T Cell-Based Immunotherapies for Solid Tumors

Alice McCarthy -
0
immune system
News & Features

Cullinan Nets $280M Investment and Targets CD19 in Lupus

Malorye Branca -
0
123...8Page 1 of 8

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine